Entropy Neurodynamics Reports Rapid, Consistent Effects in IV Psilocin Trial for Binge Eating Disorder
Early clinical data presented at the ECNP Congress show predictable psychedelic effects and measurable changes in brain activity, as the ...
Early clinical data presented at the ECNP Congress show predictable psychedelic effects and measurable changes in brain activity, as the ...
Melbourne-based Entropy Neurodynamics is advancing an intravenous psilocin programme spanning binge eating disorder, depression and other neuropsychiatric conditions, with recent ...
Australian biotechnology company Entropy Neurodynamics (ASX: ENP) has reported encouraging topline results from the first cohort of its Phase 2 ...
Psychedelics.media delivers trusted news, intelligence, and insights for the global psychedelic medicine industry.
